Pharmaceutical Industry Information Portal

HomePharmaceutical Investing News

Pharmaceutical Investing News

SK Biopharmaceuticals revenues fell 70% in the first quarter

SK Biopharmaceuticals’ sales plummeted in the first quarter, compared to a year earlier, due to the base effect of a one-off income from a...

Merck KGaA expects adjusted profit to rise to 9% due to demand for laboratory products

Germany's Merck KGaA said it expects earnings growth of up to 9% this year, mainly driven by drugmakers' demand for its laboratory gear business,...

Roche’s 2nd cancer immunotherapy trial fails, shares down the most in a year

Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of...

Bavarian Nordic starts share buy-back program

Bavarian Nordic A/S May 9th announced the initiation of a new share buy-back program, under which the Company intends to buy back up to...

Takeda Pharmaceutical expected fourth-quarter net income to decline

Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...
spot_img

Expert Articles

spot_img